Ching-Fei Li
Impact in
- Immunology top 10%
- Galectins and Cancer Biology
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
-
- Galectins and Cancer Biology 3
- Macrophage Migration Inhibitory Factor 1
- Toxin Mechanisms and Immunotoxins 1
-
- Wnt/β-catenin signaling in development and cancer 1
- Fibroblast Growth Factor Research 1
- Co-authors
- Mien‐Chie Hung (2 shared papers)Linlin Sun (2 shared papers)Ri‐Yao Yang (2 shared papers)Jong‐Ho Cha (1 shared paper)Meisi Yan (1 shared paper)Jung-Mao Hsu (1 shared paper)Xian Wen Sun (1 shared paper)Chao‐Kai Chou (1 shared paper)
- Journals
- Nature Cell Biology (1 paper)Cancer Letters (1 paper)Journal of Biological Chemistry (1 paper)Nature Communications (1 paper)Oncotarget (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Ching-Fei Li
4 papers receiving 555 citations
Ching-Fei Li's Hit Papers
Peers
Comparison fields: 5 of 66
- Immunology 329
- Oncology 271
- Cancer Research 84
- Molecular Biology 210
- Neurology 17
Countries citing papers authored by Ching-Fei Li
This map shows the geographic impact of Ching-Fei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching-Fei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching-Fei Li more than expected).
Fields of papers citing papers by Ching-Fei Li
This network shows the impact of papers produced by Ching-Fei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching-Fei Li. The network helps show where Ching-Fei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ching-Fei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy Hit paper breakdown → | 2021 | 405 |
| 2 | 2019 | 116 | |
| 3 | 2022 | 23 | |
| 4 | 2017 | 13 | |
| 5 | 2025 | 0 |
About Ching-Fei Li
Ching-Fei Li is a scholar working on Immunology, Molecular Biology, Mechanical Engineering, Oncology and Hematology, having authored 5 papers that have together received 557 indexed citations. Recurring topics across this work include Galectins and Cancer Biology (3 papers), Aluminum Alloys Composites Properties (2 papers), Silicon Carbide Semiconductor Technologies (1 paper), Macrophage Migration Inhibitory Factor (1 paper), Barrier Structure and Function Studies (1 paper), Wnt/β-catenin signaling in development and cancer (1 paper), Fibroblast Growth Factor Research (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Immunology (329 citations), Oncology (271 citations), Cancer Research (84 citations), Molecular Biology (210 citations) and Neurology (17 citations). Ching-Fei Li has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Mien‐Chie Hung, Linlin Sun, Ri‐Yao Yang, Jong‐Ho Cha, Meisi Yan, Jung-Mao Hsu, Xian Wen Sun, Chao‐Kai Chou, Yuhan Wang and Hui Li. Their work appears in journals such as Nature Cell Biology, Cancer Letters, Journal of Biological Chemistry, Nature Communications and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.